Helle Linnebjerg
5PUBLICATIONS
10CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Feb 23, 2026
Characterisation of steady-state pharmacokinetics and glucodynamics of once-weekly insulin efsitora alfa in individuals with type 2 diabetes.Jennifer Leohr, Oliver Klein, Tim Heise
|Mar 28, 2023
Ultra rapid lispro showed greater reduction in postprandial glucose versus Humalog in children, adolescents and adults with type 1 diabetes mellitus.Ronnie Aronson, Torben Biester, Jennifer Leohr
|May 22, 2020
Ultra rapid lispro lowers postprandial glucose and more closely matches normal physiological glucose response compared to other rapid insulin analogues: A phase 1 randomized, crossover study.Tim Heise, Helle Linnebjerg, David Coutant
|Jan 10, 2018
Basal insulin peglispro increases lipid oxidation, metabolic flexibility, thermogenesis and ketone bodies compared to insulin glargine in subjects with type 1 diabetes mellitus.Niels K Porksen, Helle Linnebjerg, Eric Chen Quin Lam
|Aug 18, 2017
Attenuated suppression of lipolysis explains the increases in triglyceride secretion and concentration associated with basal insulin peglispro relative to insulin glargine treatment in patients with type 1 diabetes.Rakel F Johansen, Esben Søndergaard, Helle Linnebjerg
Pageof 1
Frequent Collaborators
3 joint publications
Jennifer Leohr
2 joint publications
Tim Heise
2 joint publications
Eric Zijlstra
1 joint publications
Christoph Kapitza
1 joint publications
Juliana Bue-Valleskey
1 joint publications
Ronnie Aronson
1 joint publications
Torben Biester
1 joint publications
Robyn Pollom
1 joint publications
Thomas Danne
1 joint publications
Edward Pratt
